01/13/2026
Apyx Medical closed out 2025 with strong momentum in Surgical Aesthetics.
Preliminary, unaudited results for the fourth quarter reflect meaningful year-over-year growth, driven by continued demand for Renuvion and the commercial launch of AYON.
With both platforms now in the market, Apyx Medical is well-positioned to support the evolving needs of aesthetic surgeons, including increased demand for post-weight-loss body contouring procedures.
This performance underscores the impact of innovation aligned with market demand.
👉 Read the full press release:
apyxmedical.com/apyx-medical-corporation-reports-preliminary-unaudited-fourth-quarter-and-full-year-2025-revenue-results/